RxDoctor Payments DataLook up a doctor →

Kathryn Polovitz, MD

Internal Medicine · Parker, CONPI 1457557191

Payments from drug & device makers

$402,741in general payments, 2019–2025

Across 1,201 payments — averaging $335.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Livanova USA, Inc.$379K
  • Greenwich Biosciences, Inc.$12K
  • AbbVie$1K
  • UCB, Inc.$1K
  • Neurocrine Biosciences, Inc.$599
  • SK Life Science, Inc.$476
  • plus $8K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Livanova USA, Inc.522$379,107
Greenwich Biosciences, Inc.32$11,729
AbbVie(2 entities)96$1,320
UCB, Inc.37$1,040
Neurocrine Biosciences, Inc.30$599
SK Life Science, Inc.21$476
Novartis39$463
Eisai Inc.22$431
Teva Pharmaceuticals USA, Inc.34$414
Biohaven Pharmaceutical Holding Company Ltd.22$403
Supernus Pharmaceuticals, Inc.28$394
Amgen22$386
Bristol Myers Squibb17$369
Biogen16$318
Lilly USA, LLC18$315
Sanofi15$301
Neuropace, Inc.6$292
Lundbeck LLC8$273
Jazz Pharmaceuticals Inc.10$258
AstraZeneca12$250
Biohaven Pharmaceuticals, Inc.17$229
MDD US Operations, LLC12$221
Tanabe Pharma America, Inc.10$219
EMD Serono, Inc.10$203
Avanir Pharmaceuticals, Inc.10$179
Neurelis, Inc.7$174
Acadia Pharmaceuticals Inc10$167
Akcea Therapeutics, Inc.8$163
Pfizer8$134
Argenx US, Inc.5$131
Medtronic(2 entities)5$124
Sunovion Pharmaceuticals Inc.7$92
Catalyst Pharmaceuticals, Inc.4$78
Amneal Pharmaceuticals LLC4$75
Mallinckrodt Hospital Products Inc.4$75
Johnson & Johnson3$72
Merz Pharmaceuticals, LLC3$68
Abbott4$68
Octapharma USA, Inc.3$67
Alnylam Pharmaceuticals Inc.3$65
Assertio Therapeutics, Inc.4$63
Acorda Therapeutics, Inc3$62
Zyla Life Sciences, Inc.4$61
Upsher-smith Laboratories LLC3$57
CSL Behring3$56
Boston Scientific3$51
Collegium Pharmaceutical, Inc.3$49
Kyowa Kirin, Inc.2$41
Arbor Pharmaceuticals, Inc.3$40
Mallinckrodt Enterprises LLC3$40
E.r. Squibb & Sons, L.L.C.2$39
Scilex Pharmaceuticals Inc.2$38
Otsuka America Pharmaceutical, Inc.2$36
Impel Pharmaceuticals Inc.2$36
GRT US Holding, Inc.2$34
Xeris Pharmaceuticals, Inc.2$32
Merz North America, Inc.2$32
Zogenix Inc.1$26
Sandoz1$23
Banner Life Sciences, LLC1$23

How this compares

$402,741 in reported general payments places this provider in the 95th percentile of 1,430 internal medicine providers in Colorado.

See all internal medicine providers in Colorado →

Medicare billing

Part B allowed, 2024
$20,640
Medicare patients
118
Services billed
156

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Parker

See the full list for Colorado →

Where these figures come from

Is this you, or does something look wrong? →